Glimepiride 2MG +METFORMIN 500MG TABLET Uses

How old is patient?
sponsored

Glimepiride 2MG +METFORMIN 500MG TABLET indications

An indication is a term used for the list of condition or symptom or illness for which the medicine is prescribed or used by the patient. For example, acetaminophen or paracetamol is used for fever by the patient, or the doctor prescribes it for a headache or body pains. Now fever, headache and body pains are the indications of paracetamol. A patient should be aware of the indications of medications used for common conditions because they can be taken over the counter in the pharmacy meaning without prescription by the Physician.
sponsored

Type 2 diabetes mellitus when diet, exercise and the single agent (Glimepiride 2MG +METFORMIN 500MG TABLET) do not result in adequate glycaemic control.

Glimepiride 2MG +METFORMIN 500MG TABLET description

Each tablet contains Glimepiride (Glimepiride 2MG +Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET) 500MG TABLET) 2 mg and Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET) HCl (in sustained-release form) 500 mg.

It also contains the following excipients: Hypromellose, sodium carboxymethyl cellulose, methacrylic acid copolymer dispersion, macrogol, povidone, magnesium stearate, purified water, sodium starch glycolate, lactose, titanium dioxide, microcrystalline cellulose, magnesium stearate and pregelatinized starch. Colors: Yellow ferric oxide and titanium dioxide.

Glimepiride 2MG +METFORMIN 500MG TABLET dosage

In principle, the dosage of Glimepiride 2MG +METFORMIN 500MG TABLET is governed by the desired blood glucose level. The starting dose of Glimepiride 2MG +METFORMIN 500MG TABLET is 1 tab once a day before or with breakfast or first main meal. The dosage of Glimepiride 2MG +METFORMIN 500MG TABLET must be the lowest which is sufficient to achieve the desired metabolic control.

During treatment with Glimepiride 2MG +METFORMIN 500MG TABLET, glucose levels in blood and urine must be measured regularly. In addition, it is recommended that regular determinations of the proportion of glycated haemoglobin be carried out.

Mistakes eg, forgetting to take a dose, must never be corrected by subsequently taking a larger dose.

Measures for dealing with such mistakes (in particular, forgetting a dose or skipping a meal) or situations where a dose cannot be taken at the prescribed time must be discussed and agreed between physician and patient beforehand.

As an improvement in control of diabetes is, in itself, associated with higher insulin sensitivity, Glimepiride (Glimepiride 2MG +Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET) 500MG TABLET) requirements may fall as treatment proceeds. To avoid hypoglycaemia, timely dose reduction or cessation of Glimepiride 2MG +METFORMIN 500MG TABLET therapy must therefore be considered.

The highest recommended dose per day should be Glimepiride (Glimepiride 2MG +Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET) 500MG TABLET) 8 mg and Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET) 2000 mg.

Daily doses of Glimepiride (Glimepiride 2MG +Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET) 500MG TABLET) of >6 mg are more effective only in a minority of patients.

In order to avoid hypoglycaemia, the starting dose of Glimepiride 2MG +METFORMIN 500MG TABLET should not exceed the daily doses of Glimepiride (Glimepiride 2MG +Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET) 500MG TABLET) or Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET) already being taken.

When switching from combination therapy of Glimepiride (Glimepiride 2MG +Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET) 500MG TABLET) plus Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET) as separate tablets, Glimepiride 2MG +METFORMIN 500MG TABLET should be administered on the basis of dosage currently being taken.

Titration: The daily dose should be titrated in increments of 1 tab only, corresponding to the lowest strength (in case various strengths are available).

Duration of Treatment: Treatment with Glimepiride 2MG +METFORMIN 500MG TABLET is normally a long-term therapy.

Administration: Glimepiride 2MG +METFORMIN 500MG TABLET should be administered once per day during breakfast or at the first main meal. Due to the sustained-release formulation, Glimepiride 2MG +METFORMIN 500MG TABLET must be swallowed whole and not crushed or chewed.

Glimepiride 2MG +METFORMIN 500MG TABLET interactions

sponsored

Cimetidine: Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET) interacts with cimetidine. Therefore, the dose of Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET) should be reduced if cimetidine is co-prescribed.

Hyperglycemic Agents: Drugs with hyperglycemic potential (eg, thiazides, corticosteroids and others) may partly offset the antihyperglycemic action of Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET), and in such cases, the glycemic control should be closely monitored.

Alcohol: Alcohol potentiates the action of Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET) on lactate metabolism as well as the antihyperglycemic effect. Hence, patients treated with Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET) should preferably avoid alcohol and alcoholism is a definite contraindication.

Other Interactions: Studies with furosemide and nifedipine suggest a possible interaction by increasing plasma Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET) levels. However, no such changes were found with propranolol and ibuprofen.

The absorption of Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET) may be reduced by acarbose and guar gum. Hypoglycemia due to interaction with Glimepiride (Glimepiride 2MG +Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET) 500MG TABLET) may occur when one of the following medicines is taken eg, insulin and other oral antidiabetics, angiotensin-converting enzymes (ACE) inhibitors, allopurinol, anabolic steroids and male sex hormones, chloramphenicol, coumarin derivatives, cyclophosphamide, disopyramide, fenfluramine, fenyramidol, fibrates, fluoxetine, guanethidine, isofamide, monoamine oxidase (MAO) inhibitors, miconazole, para-aminosalicylic acid, pentoxifylline (high-dose parenteral), phenylbutazone, azapropazone, oxyphenbutazone, probenecid, quinolones, salicylates, sulfinpyrazone, sulfonamides, tetracyclines, tritoqualine, trofosfamide. Hyperglycemia due to interaction with Glimepiride (Glimepiride 2MG +Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET) 500MG TABLET) may occur when one of the following medicines is taken eg, acetazolamide, barbiturates, corticosteroids, diazoxide, diuretics, epinephrine (adrenaline) and other sympathomimetic agents, glucagons, laxatives (after protracted use), nicotinic acid (in high doses), estrogens and progestogens, phenothiazines, phenytoin, rifampicin, thyroid hormones. H2-receptor antagonists, clonidine and reserpine may lead to either potentiation or weakening of the blood sugar-lowering effect. Beta-blockers may increase the tendency to hypoglycemia.

The effect of coumarin derivatives may be potentiated or weakened.

Glimepiride 2MG +METFORMIN 500MG TABLET side effects

sponsored

Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET) may provoke or augment lactic acidosis particularly if it is present in high concentrations in the blood. Some of the symptoms of lactic acidosis may mimic certain adverse effects of Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET).

Physicians should instruct their patients to recognize the onset of symptoms of lactic acidosis to avoid this adverse reaction.

There is a great potential risk for hypoglycemia to occur due to the sulfonylurea component of Glimepiride 2MG +METFORMIN 500MG TABLET.

Possible symptoms include headache, ravenous hunger, nausea, vomiting, lassitude, sleepiness, disordered sleep, restlessness, aggressiveness, impaired concentration, impaired alertness and reactions, depression, confusion, speech disorders, aphasia, visual disorders, tremor, pareses, sensory disturbances, dizziness, helplessness, loss of self-control, delirium, cerebral convulsions, somnolence, and loss of consciousness up to and including coma, shallow respiration and bradycardia.

Reported Adverse Events to Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET) are as Follows: Gastrointestinal: Adverse effects appear to be dose-related and include diarrhea, nausea, vomiting, abdominal discomfort (eg, abdominal cramps or pain), abnormal stools, constipation, abdominal distention, dyspepsia, epigastric discomfort, flatulence, viral gastroenteritis, taste disturbance specifically metallic taste in the mouth, toothache, tooth abscess. Most of these reactions are transient and can be controlled by taking Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET) with meals or by a temporary reduction in dosage.

Body as a Whole: Chills, flu syndrome, fatigue, lethargy, asthenia, accidental injury, headache, infection

Cardiovascular: Chest discomfort/pain, hypertension, palpitations

Hematologic: Vitamin B12 and folate malabsorption, thrombocytopenia, neutropenia and rare reports of megaloblastic anemia

Hepatic: Severe acute hepatitis associated with liver function tests abnormalities and cholestasis have been associated with long-term Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET) therapy resolving upon discontinuation of Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET).

Endocrine Effects: Hypoglycemia may occur when Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET) is given concomitantly with sulfonylureas and/or alcohol; hyperglycemia (NOS) and sexual dysfunction.

Musculoskeletal: Asthenia, muscle cramp, muscle strain, myalgia, pain in limb.

Nervous System: Agitation, dizziness, migraine, paresthesia, syncope, sinus headache, hypoesthesia, lightheadedness, tremor.

Respiratory: Dyspnea, flu syndrome, nasal congestion, sinus congestion, rhinorrhea, rhinitis, tonsillitis, upper respiratory infection.

Skin and Appendages: Rash, erythema, pruritus, urticaria, increased sweating, contusion.

Others: Pneumonitis with vasculitis, aggravated edema, peripheral edema, ear pain, blurred vision, fungal infection, flushing, nail disorder and seasonal allergy.

The profile of adverse reactions in pediatric patients is similar to those observed in adults.

Laboratory Findings: Decreased blood glucose, abnormal liver function tests and increased white blood cell count.

Reported Adverse Events to Glimepiride (Glimepiride 2MG +Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET) 500MG TABLET) are as Follows: Metabolic-Nutritional: Hypoglycemia, hyperglycemia, hyponatremia, increased appetite, dyspepsia, anorexia.

Gastrointestinal (GI): Diarrhea, nausea, vomiting, abdominal discomfort, abdominal distention, sensation of fullness.

Cardiovascular: Hypertension, tachycardia, bradycardia, palpitations, angina pectoris, cardiac arrhythmias, vasodilation.

Hematologic: Hemolytic and aplastic anemia, leukopenia, agranulocytosis, thrombocytopenia, thrombocytopenic purpura, pancytopenia due to myelosuppression, eosinophilia, erythrocytopenia, granulocytopenia.

Central Nervous System: Disulfiram-like reactions, headache, dizziness, lassitude, sleepiness, disordered sleep, restlessness, aggressiveness, impaired concentration, alertness and reaction time, depression, confusion, aphasia, tremor, paresis, sensory disturbance, helplessness, loss of self-control, delirium, cerebral convulsions, somnolence and loss of consciousness up to and including coma.

Hepatobiliary: Cholestasis, jaundice, abnormal liver function, hepatitis which may lead to liver failure or hepatic dysfunction, hepatic porphyria reactions, increased liver enzyme levels, granulomatous hepatitis, bilirubinemia.

Skin and Subcutaneous Tissue Disorders: Allergic or pseudo-allergic skin reactions (eg, pruritus, erythema, urticaria, vasculitis, and morbilliform or maculopapular eruptions). Such mild reactions may develop into serious reactions with dyspnea and hypotension, sometimes progressing to shock. These may be transient and may disappear despite continued use of Glimepiride (Glimepiride 2MG +Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET) 500MG TABLET). If skin reactions persist, the drug should be discontinued. Porphyria cutanea tarda, photosensitivity reactions and clammy skin were also observed.

Miscellaneous: Asthenia, allergic vasculitis, sweating, impaired speech disorder, visual disturbance/abnormal vision, dyspnea, increased urinary frequency.

Glimepiride 2MG +METFORMIN 500MG TABLET contraindications

sponsored

Patients hypersensitive to Glimepiride (Glimepiride 2MG +Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET) 500MG TABLET), Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET), other sulfonylureas, other sulfonamides or any of the excipients of Glimepiride 2MG +METFORMIN 500MG TABLET.

Glimepiride (Glimepiride 2MG +Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET) 500MG TABLET): No experience has been gained concerning the use of Glimepiride (Glimepiride 2MG +Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET) 500MG TABLET) in patients with severe impairment of liver function and in dialysis patients. In patients with severe impairment of hepatic function, changeover to insulin is indicated, not least to achieve optimal metabolic control.

Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET): Diabetic ketoacidosis, diabetic pre-coma.

Renal failure or renal dysfunction (eg, serum creatinine levels >135 micromol/L in males and >110 micromol/L in females).

Acute conditions with the potential to alter renal function eg, dehydration, severe infection, shock, intravascular administration of iodinated contrast agents.

Acute or chronic disease which may cause tissue hypoxia eg, cardiac or respiratory failure, recent myocardial infarction, shock.

Hepatic insufficiency; acute alcohol intoxication, alcoholism.

Use in pregnancy & lactation: Glimepiride (Glimepiride 2MG +Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET) 500MG TABLET): Glimepiride (Glimepiride 2MG +Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET) 500MG TABLET) must not be taken during pregnancy. Otherwise, there is risk of harm to the child. The patient must changeover to insulin during pregnancy.

Patients planning a pregnancy must inform their physician. It is recommended that such patients changeover to insulin.

To prevent possible ingestion with the breast milk and possible harm to the child, Glimepiride (Glimepiride 2MG +Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET) 500MG TABLET) must not be taken by breastfeeding women. If necessary, the patient must changeover to insulin or must stop breastfeeding.

Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET): To date, no relevant epidemiological data are available. Animal studies do not indicate harmful effects with respect to pregnancy, embryonal or fetal development, parturition or postnatal development.

When the patient plans to become pregnant and during pregnancy, diabetes should not be treated with Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET) but insulin should be used to maintain blood glucose levels as close to normal as possible in order to lower the risk of fetal malformations associated with abnormal blood glucose levels.

Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET) is excreted into milk in lactating rats. Similar data are not available in humans and a decision should be made whether to discontinue nursing or to discontinue Metformin (Glimepiride 2MG +METFORMIN 500MG TABLET), taking into account the importance of the compound to the mother.



Active ingredient matches for Glimepiride 2MG +METFORMIN 500MG TABLET:

Glimepiride/Metformin


Unit description / dosage (Manufacturer)Price, USD
GLIMEPIRIDE 2MG +METFORMIN 500MG TABLET 1 strip / 10 tablet srs each (Jan Aushadhi)$ 0.28

List of Glimepiride 2MG +METFORMIN 500MG TABLET substitutes (brand and generic names):

Glimerin-M Glimepiride 1 mg, Metforminhydrochloride 500 mg. TAB / 10 (Rhine Biogenics)$ 0.60
Glimerin-M Glimepiride 2 mg, Metforminhydrochloride 500 mg TAB / 10 (Rhine Biogenics)$ 0.71
10's (Rhine Biogenics)$ 0.71
GLIMERIN-M tab 10's (Rhine Biogenics)$ 0.71
GLIMESTAR M 1 FORTE TABLET SR 1 strip / 30 tablet srs each (Mankind Pharma Ltd)$ 2.62
GLIMESTAR M 1 FORTE TABLET SR 1 strip / 10 tablet srs each (Mankind Pharma Ltd)$ 0.87
GLIMESTAR M -1 TABLET SR 1 strip / 30 tablet srs each (Mankind Pharma Ltd)$ 2.04
GLIMESTAR M -1 TABLET SR 1 strip / 10 tablet srs each (Mankind Pharma Ltd)$ 0.68
GLIMESTAR M 2 FORTE TABLET SR 1 strip / 30 tablet srs each (Mankind Pharma Ltd)$ 3.81
GLIMESTAR M -2 TABLET SR 1 strip / 30 tablet srs each (Mankind Pharma Ltd)$ 3.11
GLIMESTAR M 3 FORTE TABLET SR 1 strip / 10 tablet srs each (Mankind Pharma Ltd)$ 1.54
GLIMESTAR M -3 TABLET 1 strip / 10 tablets each (Mankind Pharma Ltd)$ 0.95
GLIMESTAR M 4 FORTE TABLET SR 1 strip / 10 tablet srs each (Mankind Pharma Ltd)$ 1.73
GLIMESTAR M -4 TABLET 1 strip / 10 tablets each (Mankind Pharma Ltd)$ 1.11
Glimestar-M Capsule/ Tablet / 1mg-500mg / 10 units (Mankind)$ 0.52
Glimestar-M Glimepiride 1 mg, Metforminhydrochloride 500 mg. TAB / 10 (Mankind)$ 0.43
Glimestar-M Glimepiride 2 mg, Metforminhydrochloride 500 mg. TAB / 10 (Mankind)$ 0.65
10's (Mankind)$ 0.55
GLIMESTAR-M1 TABLET SR 1 strip / 30 tablet srs each (Mankind)$ 2.04
GLIMESTAR-M1 TABLET SR 1 strip / 10 tablet srs each (Mankind)$ 0.68
GLIMESTAR-M2 TABLET SR 1 strip / 30 tablet srs each (Mankind)$ 3.11
GLIMESTAR-M 1 FORTE TABLET SR 1 strip / 10 tablet srs each (Mankind)$ 2.62
GLIMESTAR-M 2 FORTE TABLET SR 1 strip / 30 tablet srs each (Mankind)$ 3.81
GLIMESTAR-M 3 FORTE TABLET SR 1 strip / 10 tablet srs each (Mankind)$ 1.54
GLIMESTAR-M 3 TABLET 1 strip / 10 tablets each (Mankind)$ 0.95
GLIMESTAR-M 4 FORTE TABLET SR 1 strip / 10 tablet srs each (Mankind)$ 1.73
GLIMESTAR-M 4 TABLET 1 strip / 10 tablets each (Mankind)$ 1.11
GLIMESTAR-M tab 10's (Mankind)$ 0.65
Glimestar-M 1 Forte Tablet (Mankind)$ 0.10
Glimestar-M 1 Tablet SR (Mankind)$ 0.07
Glimestar-M 2 Forte Tablet SR (Mankind)$ 0.14
Glimestar-M 2 Tablet SR (Mankind)$ 0.11
Glimestar-M 3 Forte Tablet (Mankind)$ 0.15
Glimestar-M 3 Tablet (Mankind)$ 0.11
Glimestar-M 4 Forte Tablet SR (Mankind)$ 0.17
Glimestar-M 4 Tablet (Mankind)$ 0.13
Glimet Capsule/ Tablet / 2.5mg-250mg / 10 units (Neiss Labs Pvt. Ltd.)$ 0.08
Glimet Capsule/ Tablet / 5mg-500mg / 10 units (Neiss Labs Pvt. Ltd.)$ 0.12
Glimet Glipizide 2.5mg, Metformin HCI250mg TAB / 10 (Neiss Labs Pvt. Ltd.)$ 0.06
Glimet 30's (Neiss Labs Pvt. Ltd.)
10's (Neiss Labs Pvt. Ltd.)$ 0.06
Glimet 80+500 Tablet (Neiss Labs Pvt. Ltd.)$ 0.06
Glimet 2.5+250 Tablet (Neiss Labs Pvt. Ltd.)$ 0.01
GLIMET 2.5 MG/250 MG TABLET 1 strip / 10 tablets each (Neiss Labs Pvt. Ltd.)$ 0.06
GLIMET DS 5 MG/500 MG TABLET 1 strip / 10 tablets each (Neiss Labs Pvt. Ltd.)$ 0.18
GLIMET tab 10's (Neiss Labs Pvt. Ltd.)$ 0.05
Glimet Tablet (Neiss Labs Pvt. Ltd.)$ 0.01
GLIMET-M tab 10's (Impact)
Tablet; Oral; Glimepiride 1 mg; Metformin Hydrochloride 500 mg (Silanes)
Tablet; Oral; Glimepiride 2 mg; Metformin Hydrochloride 1 g (Silanes)
Tablet; Oral; Glimepiride 4 mg; Metformin Hydrochloride 1 g (Silanes)
Tablet, Extended Release; Oral; Glimepiride 2 mg; Metformin Hydrochloride 1 g
Tablet, Extended Release; Oral; Glimepiride 2 mg; Metformin Hydrochloride 850 mg
Tablet, Extended Release; Oral; Glimepiride 4 mg; Metformin Hydrochloride 1 g
Tablet, Extended Release; Oral; Glimepiride 4 mg; Metformin Hydrochloride 850 mg
GLIMETES PLUS 1MG/500MG TABLET 1 strip / 10 tablets each (Mova Pharmaceutical Pvt Ltd)$ 0.64
GLIMETONE M 1MG/500MG TABLET 1 strip / 10 tablets each (Maneesh Pharmaceuticals Ltd)$ 0.94

References

  1. DailyMed. "GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
  2. PubChem. "metformin". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
  3. PubChem. "glimepiride". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).

Reviews

The results of a survey conducted on ndrugs.com for Glimepiride 2MG +METFORMIN 500MG TABLET are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Glimepiride 2MG +METFORMIN 500MG TABLET. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

Consumer reported useful

No survey data has been collected yet


Consumer reported price estimates

No survey data has been collected yet


Consumer reported time for results

No survey data has been collected yet


Consumer reported age

No survey data has been collected yet


Consumer reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 2 here

Information checked by Dr. Sachin Kumar, MD Pharmacology

| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2022 ndrugs.com All Rights Reserved